Question 1

What are the most cited papers from Riemser Pharma (Germany)?

Accepted Answer

The most cited paper from Riemser Pharma (Germany) is "Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool" (Thomas Hoenen et al., 2015), with 241 citations. Next come "Comparison of Porcine Epidemic Diarrhea Viruses from Germany and the United States, 2014" (136) and "Development of an oral vaccine for immunisation of rainbow trout (Oncorhynchus mykiss) against viral haemorrhagic septicaemia" (118).

Question 2

Which research topics does Riemser Pharma (Germany) publish most on?

Accepted Answer

By volume in 2022-now: AI and HR Technologies, Innovations and Analysis in Business and Education, Vector-Borne Animal Diseases and Internet of Things and AI.

Question 3

Which keywords describe research at Riemser Pharma (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Genetic Characterization, Vaccine, Viral Pathogenesis, Immune Response, African Swine Fever and Foot-and-Mouth Disease.

Question 4

Which fields of science does Riemser Pharma (Germany) work in?

Accepted Answer

In all years, 43% of research at Riemser Pharma (Germany) is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (39%), Agricultural and Biological Sciences (23%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.1× the world's share of Life Sciences.

Question 5

Is Riemser Pharma (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 8% lower than in 2018-2021.